Julius-von-Sachs-Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs-Platz 3, 97082, Würzburg, Germany.
Mar Biotechnol (NY). 2011 Oct;13(5):883-92. doi: 10.1007/s10126-010-9349-0. Epub 2011 Jan 11.
Marine sponges and their associated bacteria have been proven to be a rich source of novel secondary metabolites with therapeutic usefulness in cancer, infection, and autoimmunity. In this study, 79 strains belonging to 20 genera of the order Actinomycetales and seven strains belonging to two genera of the order Sphingomonadales were cultivated from 18 different Caribbean sponges and identified by 16S rRNA gene sequencing. Seven of these strains are likely to represent novel species. Crude extracts from selected strains were found to exhibit protease inhibition against cathepsins B and L, rhodesain, and falcipain-2 as well as immunomodulatory activities such as induction of cytokine release by human peripheral blood mononuclear cells. These results highlight the significance of marine sponge-associated bacteria to produce bioactive secondary metabolites with therapeutic potential in the treatment of infectious diseases and disorders of the immune system.
海洋海绵及其相关细菌已被证明是新型次生代谢物的丰富来源,这些次生代谢物在癌症、感染和自身免疫方面具有治疗用途。在这项研究中,从 18 种不同的加勒比海绵中培养了属于放线菌目 20 个属的 79 株和属于鞘氨醇单胞菌目 2 个属的 7 株细菌,并通过 16S rRNA 基因测序进行了鉴定。其中 7 株可能代表新种。从选定的菌株中提取的粗提取物被发现对组织蛋白酶 B 和 L、rhodesain 和 falcipain-2 具有蛋白酶抑制作用,以及免疫调节活性,如诱导人外周血单核细胞释放细胞因子。这些结果突出了海洋海绵相关细菌产生具有治疗潜力的生物活性次生代谢物的重要性,可用于治疗传染病和免疫系统疾病。